The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Boris Johnson: "significant milestone" as over 50s offered Covid jab

Tue, 13th Apr 2021 09:07

(Alliance News) - All adults in the UK aged over 50 have now been offered a first dose of a coronavirus vaccine, paving the way for the next phase of the rollout, the UK government has said.

Boris Johnson hailed another "hugely significant milestone" in the programme to protect the country against the disease.

It means the government has met its target of offering the jab to all of its top nine priority groups, including the clinically vulnerable and health and social care workers, three days ahead of its target date of April 15.

The Joint Committee on Vaccine and Immunisation will shortly set out its final advice for the completion of the programme, expected to begin this week with those in their late 40s.

The announcement comes after Ireland became the latest country to restrict the use of the AstraZeneca PLC vaccine, saying it should not be given to people under the age of 60, amid concerns over possible links to rare blood clotting events.

In the UK, the advice is that it should not be administered to those under 30.

In all, the government said almost 40 million doses of the Pfizer and AstraZeneca vaccines have been delivered since the rollout began in the UK in December, including 32 million first jabs and more than seven million second doses.

In a statement, Johnson said that they remained on course to offer a first jab to all adults in the UK by the end of July.

"We have now passed another hugely significant milestone in our vaccine programme by offering jabs to everyone in the nine highest risk groups," he said.

"That means more than 32 million people have been given the precious protection vaccines provide against Covid 19.

"I want to thank everyone involved in the vaccine rollout which has already saved many thousands of lives.

"We will now move forward with completing essential second doses and making progress towards our target of offering all adults a vaccine by the end of July."

NHS patients in England are also set to receive the Moderna Covid-19 vaccine from Tuesday.

Professor Stephen Powis, medical director for NHS England, said: "We now have a third jab in our armoury and NHS staff will be using it at more than 20 sites from this week, with more coming online as supplies expand."

NHS England chief executive Simon Stevens said 19 out of 20 over 50s had now received a first jab.

"Thanks to our NHS nurses, doctors, pharmacists, operational managers and thousands of other staff and volunteers, the NHS Covid vaccination programme is without a doubt the most successful in our history," he said.

"It's one of our tickets out of this pandemic and offers real hope for the future."

The announcement comes despite an earlier warning by the NHS in England of a "significant reduction in weekly supply" during April, meaning volumes for first doses would be "significantly constrained".

Throughout the current month, the health service has prioritised second doses of the Pfizer and AstraZeneca vaccines with a record 475,230 people receiving their second jab on Saturday.

Meanwhile, there is to be a surge in testing in the boroughs Lambeth and Wandsworth in south London following the identification of a number of cases of a variant of the virus first found in South Africa.

Dozens of people were told to isolate after the Department for Health and Social Care said there had been 44 confirmed cases of the strain, with a further 30 suspected.

It came as scenes posted on social media of revellers gathering in Soho, central London, following the latest easing of lockdown restrictions in England were lifted, prompted fears that social distancing guidelines were being ignored.

Chris Hopson, chief executive of NHS Providers, which represents NHS Trusts, said it was still important to prevent the spread of the disease following the "incredible achievement" of the vaccination programme.

"While there is still a way to go with our vaccination programme, we welcome the progress being made, with the jabs due to be rolled out to the over 40s this week and all priority groups now offered a first dose," he said.

"As we return to pub gardens and sports activities and make our way back to non-essential shops, we must continue do all that we can to prevent the spread of infection and ensure this lockdown will be the last."

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.